Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly-Reference-Cited by-同舟云学术

Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly

Published:2019-07-24 Issue:3 Volume:20 Page:365-381
ISSN:1389-9155
Container-title:Reviews in Endocrine and Metabolic Disorders
language:en
Short-container-title:Rev Endocr Metab Disord

Author:

Gatto Federico,Campana Claudia,Cocchiara Francesco,Corica Giuliana,Albertelli Manuela,Boschetti Mara,Zona Gianluigi,Criminelli Diego,Giusti Massimo,Ferone Diego^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11154-019-09506-y.pdf

Reference143 articles.

1. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355(24):2558–73. https://doi.org/10.1056/NEJMra062453 .

2. Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933–51. https://doi.org/10.1210/jc.2014-2700 .

3. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102–52. https://doi.org/10.1210/er.2002-0022 .

4. Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol. 2008;159(2):89–95. https://doi.org/10.1530/EJE-08-0267 .

5. Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, et al. Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary. 2017;20(5):489–98. https://doi.org/10.1007/s11102-017-0838-2 .

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best practice and research, clinical endocrinology and metabolism preface to the special issue: Diagnosis and treatment of acromegaly acromegaly, a paradigmatic disease second part: Treatment;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

2. Serum Phosphorus and Calcium as Biomarkers of Disease Status in Acromegaly;Biomedicines;2023-12-11

3. Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs;Journal of Endocrinological Investigation;2023-09-11

4. Case report: Optimizing the transition from injectable to oral treatment for acromegaly;Journal of Clinical and Translational Endocrinology: Case Reports;2023-06

5. The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study;Scientific Reports;2023-02-25